Published in Neurology on July 08, 2003
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord (2005) 2.19
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord (2013) 2.01
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol (2008) 1.81
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain (2015) 1.71
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol (2010) 1.38
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol (2014) 1.37
Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun (2008) 1.20
Gender differences in the risk of familial parkinsonism: beyond LRRK2? Neurosci Lett (2011) 1.07
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc (2010) 1.04
Accuracy of family history information on epilepsy and other seizure disorders. Neurology (2011) 0.99
Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genet Med (2012) 0.96
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium. Neurology (2015) 0.93
Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease. J Neurol Sci (2006) 0.93
Nonparametric estimation for censored mixture data with application to the Cooperative Huntington's Observational Research Trial. J Am Stat Assoc (2012) 0.92
Medicare capitation model, functional status, and multiple comorbidities: model accuracy. Am J Manag Care (2008) 0.89
Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease. J Probab Stat (2012) 0.84
Efficient distribution estimation for data with unobserved sub-population identifiers. Electron J Stat (2012) 0.84
PD or not PD? That is the question. Neurology (2003) 0.82
Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives. J Genet Couns (2014) 0.82
Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data. Biometrika (2015) 0.81
COMBINING ISOTONIC REGRESSION AND EM ALGORITHM TO PREDICT GENETIC RISK UNDER MONOTONICITY CONSTRAINT. Ann Appl Stat (2014) 0.78
SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. NPJ Parkinsons Dis (2016) 0.78
Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis. PLoS One (2017) 0.75
Familial Aggregation and Co-Aggregation of Essential Tremor and Parkinson's Disease. Neuroepidemiology (2015) 0.75
Systematic Analysis of Free-Text Family History in Electronic Health Record. AMIA Jt Summits Transl Sci Proc (2017) 0.75
Parkinson's disease prevalence in Fabry disease: A survey study. Mol Genet Metab Rep (2017) 0.75
Estimation of genetic risk function with covariates in the presence of missing genotypes. Stat Med (2017) 0.75
Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med (1977) 24.44
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 6.03
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet (1995) 5.11
Ethical problems in the management of some severely handicapped children. J Med Ethics (1981) 5.04
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Precautionary principle stifles discovery. Nature (1999) 3.38
"Goodbye Dolly?" The ethics of human cloning. J Med Ethics (1997) 3.23
Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry (1980) 3.19
Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health (1991) 2.90
Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology (2003) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol (1996) 2.86
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet (2001) 2.81
Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol (2001) 2.72
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet (1970) 2.62
An activating mutation of AKT2 and human hypoglycemia. Science (2011) 2.60
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52
Human cloning and child welfare. J Med Ethics (1999) 2.49
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
Incentive spirometry versus routine chest physiotherapy for prevention of pulmonary complications after abdominal surgery. Lancet (1991) 2.36
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant (2010) 2.33
Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomized controlled study. J Urol (2002) 2.32
Pharmacokinetics of theophylline in children with asthma. Pediatrics (1976) 2.31
Is cloning an attack on human dignity? Nature (1997) 2.30
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther (1974) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22
Idiopathic cervical dystonia: clinical characteristics. Mov Disord (1991) 2.21
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Ankylosing hyperostosis. I. Clinical and radiological features. Ann Rheum Dis (1974) 2.17
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14
Anatomy, pathophysiology, and prevention of senile enophthalmia and associated herniated lower eyelid fat pads. Plast Reconstr Surg (1997) 2.12
The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology (2003) 2.11
Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord (1998) 2.11
Breast augmentation: compression--a very important factor in preventing capsular contracture. Plast Reconstr Surg (1999) 2.10
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Oral and genital tardive pain syndromes. Neurology (1994) 2.07
The association of incident dementia with mortality in PD. Neurology (2002) 2.07
The risks associated with pregnancy in women aged 35 years or older. Hum Reprod (2000) 2.06
Factors affecting the use of medical, mental health, alcohol, and drug treatment services by homeless adults. Med Care (1990) 2.06
What is it? Case 3, 1991: moaning in a man with parkinsonian signs. Mov Disord (1991) 2.05
Organizational difference of cell surface "hematoside" in normal and virally transformed cells. Biochem Biophys Res Commun (1968) 2.04
How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord (1998) 2.03
Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord (1995) 2.03
Distant effects of local injection of botulinum toxin. Muscle Nerve (1987) 2.02